Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults (original) (raw)
Patel, Rajan, Jeemon, Panniyammakal, Stevens, Kathryn, Mccallum, Linsay, Hastie, Claire ORCID: https://orcid.org/0000-0002-4604-3319, Schneider, Andreas, Jardine, Alan
ORCID: https://orcid.org/0000-0001-5815-9370, Mark, Patrick
ORCID: https://orcid.org/0000-0003-3387-2123 and Padmanabhan, Sandosh
ORCID: https://orcid.org/0000-0003-3869-5808(2015) Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults.Journal of Hypertension, 33(10), pp. 2046-2053. (doi: 10.1097/hjh.0000000000000659) (PMID:26431193)
Full text not currently available from Enlighten.
Abstract
Objectives: Abnormalities of bone mineral parameters are associated with cardiovascular morbidity and mortality in patients with chronic kidney disease and the general population. Methods: We assessed the impact of baseline serum phosphate and calcium on longitudinal blood pressure (BP) control and survival in hypertensive adults. We studied 9260 hypertensive adults followed for 40 years (151 789 person-years). Changes in BP over initial 5-year follow-up were analysed using generalized estimating equations. Survival analyses were performed using Cox proportional hazards model. Results: Serum phosphate levels were higher in hypertensive women (1.10 mmol/l ± 0.20) than compared to men (1.02 mmol/l ± 0.21). In treated hypertensive patients, higher baseline serum phosphate was significantly associated with poor longitudinal SBP reduction (one standard deviation increase in phosphate was associated with 0.22 and 0.59 mmHg higher SBP at 5 years in men and women, respectively). Higher serum phosphate was significantly associated with all-cause and cardiovascular mortality in men, whereas in men and women, serum calcium significantly predicted all-cause and noncardiovascular mortality. In hypertensive patients with chronic kidney disease, higher phosphate was significantly associated with poorer survival. Conclusion: In hypertensive patients, serum phosphate and calcium are significantly associated with reduced all-cause and cardiovascular survival and this appears not to be related to BP control.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Mccallum, Dr Linsay and Stevens, Dr Kathryn and Schneider, Dr Andreas and Patel, Dr Rajan and Jardine, Professor Alan and Mark, Professor Patrick and Padmanabhan, Professor Sandosh and Hastie, Dr Claire |
| Authors: | Patel, R., Jeemon, P., Stevens, K., Mccallum, L., Hastie, C., Schneider, A., Jardine, A., Mark, P., and Padmanabhan, S. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic HealthCollege of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Journal of Hypertension |
| Publisher: | Lippincott Williams & Wilkins |
| ISSN: | 0263-6352 |
| ISSN (Online): | 1473-5598 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
| ID Code: | 116332 |
|---|---|
| Depositing User: | Mrs Rachael Munro |
| Datestamp: | 10 Mar 2016 16:17 |
| Last Modified: | 02 May 2025 08:13 |
| Date of acceptance: | 12 May 2015 |
| Date of first online publication: | October 2015 |